BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang Z, Ruan YB, Guan Y, Liu SH. Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World J Gastroenterol 2003; 9(2): 267-270 [PMID: 12532445 DOI: 10.3748/wjg.v9.i2.267]
URL: https://www.wjgnet.com/1007-9327/full/v9/i2/267.htm
Number Citing Articles
1
Michael Höpfner, Alexander Huether, Andreas P. Sutter, Viola Baradari, Detlef Schuppan, Hans Scherübl. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cellsBiochemical Pharmacology 2006; 71(10): 1435 doi: 10.1016/j.bcp.2006.02.006
2
Randa A. Zaghloul, Mamdouh M. El-Shishtawy, Khaled H. Abd El Galil, Mohamed A. Ebrahim, AbdelHamid A. Metwaly, Mohammed M. Al-Gayyar. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinomaEuropean Journal of Pharmacology 2015; 746: 353 doi: 10.1016/j.ejphar.2014.11.008
3
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancerWorld Journal of Gastroenterology 2008; 14(1): 1-14 doi: 10.3748/wjg.14.1
4
Mozaffarul Islam, Smita Sharma, Bhavna Kumar, Theodoros N. Teknos. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasisOral Oncology 2013; 49(8): 778 doi: 10.1016/j.oraloncology.2013.04.003
5
Iliana Fauzi, Nicki Panoskaltsis, Athanasios Mantalaris. Enhanced Hematopoietic Differentiation Toward Erythrocytes from Murine Embryonic Stem Cells with HepG2-Conditioned MediumStem Cells and Development 2012; 21(17): 3152 doi: 10.1089/scd.2012.0030
6
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Targeted medical therapy of biliary tract cancer: Recent advances and future perspectivesWorld Journal of Gastroenterology 2008; 14(46): 7021-7032 doi: 10.3748/wjg.14.7021
7
Jian Zhuge, Ye Luo, Ying-Nian Yu. Heterologous expression of human cytochrome P450 2E1 in HepG2 cell lineWorld Journal of Gastroenterology 2003; 9(12): 2732-2736 doi: 10.3748/wjg.v9.i12.2732
8
Yulin Yuan, Xuhong Zhou, Jian Song, Xiaoping Qiu, Jun Li, Linfeng Ye, Xiaoping Meng, Dong Xia. Expression and Clinical Significance of Epidermal Growth Factor Receptor and Type 1 Insulin-Like Growth Factor Receptor in Nasopharyngeal CarcinomaAnnals of Otology, Rhinology & Laryngology 2008; 117(3): 192 doi: 10.1177/000348940811700306
9
Dan He, Hongpeng Gong, Jie Pan, Fangchao Zhu, Xiaofen Jiang, Huang Su. Recurrent Non-islet Cell Tumor Hypoglycemia Secondary to Hepatocellular Carcinoma: Case Report and Literature ReviewZeitschrift für Gastroenterologie 2024; 62(05): 752 doi: 10.1055/a-2170-1691
10
Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak, Eric Brown, Alexandra Eyzaguirre, Nianjun Tao, Maryland Rosenfeld-Franklin, Lorena Lerner, M. Isabel Chiu, Robert Wild, David Epstein, Jonathan A. Pachter, Mark R. Miglarese. Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in CancerMolecular Cancer Therapeutics 2010; 9(10): 2652 doi: 10.1158/1535-7163.MCT-10-0318
11
C. Morace, M. Cucunato, R. Bellerone, G. De Caro, S. Crinò, A. Fortiguerra, F. Spadaro, A. Zirilli, A. Alibrandi, P. Consolo, C. Luigiano, M.L. Resta, O. Ferraù, A. Spadaro. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?European Journal of Internal Medicine 2012; 23(6): e157 doi: 10.1016/j.ejim.2012.04.014
12
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver DiseasesInternational Journal of Molecular Sciences 2018; 19(5): 1308 doi: 10.3390/ijms19051308
13
Qun-sheng Ji, Mark J. Mulvihill, Maryland Rosenfeld-Franklin, Andrew Cooke, Lixin Feng, Gilda Mak, Matthew O'Connor, Yan Yao, Caroline Pirritt, Elizabeth Buck, Alexandra Eyzaguirre, Lee D. Arnold, Neil W. Gibson, Jonathan A. Pachter. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo Molecular Cancer Therapeutics 2007; 6(8): 2158 doi: 10.1158/1535-7163.MCT-07-0070
14
Kun-Peng Fang, Jian-Lin Zhang, Yan-Hong Ren, Ye-Ben Qian. Talin-1 Correlates with Reduced Invasion and Migration in Human Hepatocellular Carcinoma CellsAsian Pacific Journal of Cancer Prevention 2014; 15(6): 2655 doi: 10.7314/APJCP.2014.15.6.2655
15
J. F. Tsai, J. E. Jeng, L. Y. Chuang, H. L. You, L. Y. Wang, M. Y. Hsieh, S. C. Chen, W. L. Chuang, Z. Y. Lin, M. L. Yu, C. Y. Dai. Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinomaScandinavian Journal of Gastroenterology 2005; 40(1): 68 doi: 10.1080/00365520410009311
16
Mark J. Mulvihill, Elizabeth Buck. Accounts in Drug Discovery2010; : 71 doi: 10.1039/9781849731980-00071
17
Daphna Mokady, David Meiri. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistanceDrug Resistance Updates 2015; 19: 22 doi: 10.1016/j.drup.2015.01.001
18
Sunita Kumari, Arka De, Naveen Kalra, Virendra Singh. Growth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control TrialAmerican Journal of Gastroenterology 2024; 119(1): 116 doi: 10.14309/ajg.0000000000002300
19
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological managementBiomedicine & Pharmacotherapy 2018; 106: 991 doi: 10.1016/j.biopha.2018.06.095
20
Nearmeen M. Rashad, Amal S. El-Shal, Eman H. Abd Elbary, Mohamed H. Abo Warda, Osama Hegazy. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinomaCytokine 2014; 68(1): 50 doi: 10.1016/j.cyto.2014.02.006
21
Miloš Šunderić, Vesna Malenković, Olgica Nedić. Complexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumorExperimental and Molecular Pathology 2015; 98(2): 173 doi: 10.1016/j.yexmp.2015.03.003
22
Smruti Mohanty, Donald Jensen. Hepatocellular Carcinoma2009; : 62 doi: 10.3109/9780203092880-6
23
Seon-Hee Yim, Yeun-Jun Chung. An Overview of Biomarkers and Molecular Signatures in HCCCancers 2010; 2(2): 809 doi: 10.3390/cancers2020809
24
Motawa E. El-Houseini, Mohammed S. Mohammed, Wael M. Elshemey, Tarek D. Hussein, Omar S. Desouky, Anwar A. Elsayed. Enhanced Detection of Hepatocellular CarcinomaCancer Control 2005; 12(4): 248 doi: 10.1177/107327480501200407
25
Elizabeth Buck, Mark Mulvihill. Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancerExpert Opinion on Investigational Drugs 2011; 20(5): 605 doi: 10.1517/13543784.2011.558501
26
Jennifer Wu, Andrew X Zhu. Targeting insulin-like growth factor axis in hepatocellular carcinomaJournal of Hematology & Oncology 2011; 4(1) doi: 10.1186/1756-8722-4-30
27
Kimberly Terry, Mehmet Sitki Copur. Molecular Targeted Therapy of Hepatocellular CarcinomaJournal of Cancer Therapy 2013; 4(02): 426 doi: 10.4236/jct.2013.42A052
28
Stefania Bortoluzzi, Andrea Bisognin, Chiara Romualdi, Gian Antonio Danieli. Novel genes, possibly relevant for molecular diagnosis or therapy of human rhabdomyosarcoma, detected by genomic expression profilingGene 2005; 348: 65 doi: 10.1016/j.gene.2004.12.024
29
Li Wang, Min Yao, Zhizhen Dong, Yun Zhang, Dengfu Yao. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoringTumor Biology 2014; 35(1): 9 doi: 10.1007/s13277-013-1141-0
30
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, Josephine Diony Nanda, Ageng Brahmadhi, Thai-Yen Ling, Te-Sheng Chang, Yen-Hua Huang. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug ResistanceInternational Journal of Molecular Sciences 2021; 22(4): 1931 doi: 10.3390/ijms22041931
31
Yu-Shik Hwang, Wesley L. Randle, Robert C. Bielby, Julia M. Polak, Athanasios Mantalaris. Enhanced Derivation of Osteogenic Cells from Murine Embryonic Stem Cells After Treatment with HepG2- Conditioned Medium and Modulation of the Embryoid Body Formation Period: Application to Skeletal Tissue EngineeringTissue Engineering 2006; 12(6): 1381 doi: 10.1089/ten.2006.12.1381
32
Kai Breuhahn, Peter Schirmacher. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinomaWorld Journal of Gastroenterology 2008; 14(11): 1690-1698 doi: 10.3748/wjg.14.1690
33
Ravinder Kaur, Jatin K. Nagpal, Bibhu R. Das. Polymorphism in IGF-2 as a Surrogate Marker for Predisposition towards Tobacco Chewing-Mediated Oral CancerTumor Biology 2005; 26(3): 147 doi: 10.1159/000086486
34
Michael Höpfner, Detlef Schuppan, Hans Scherübl. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectivesWorld Journal of Gastroenterology 2008; 14(16): 2461-2473 doi: 10.3748/wjg.14.2461
35
Yuanyuan Ji, Zhidong Wang, Zongfang Li, Na Huang, Haiyan Chen, Baohua Li, Bo Hui. Silencing IGF-II impairs C-myc and N-ras expressions of SMMC-7721 cells via suppressing FAK/PI3K/Akt signaling pathwayCytokine 2017; 90: 44 doi: 10.1016/j.cyto.2016.10.008
36
Giuseppe Tonini, Vladimir Virzì, Maria Elisabetta Fratto, Bruno Vincenzi, Daniele Santini. Targeted Therapy in Biliary Tract Cancer: 2009 UpdateFuture Oncology 2009; 5(10): 1675 doi: 10.2217/fon.09.130
37
Weiwei Gui, Yiyi Zhu, Shuiya Sun, Weifen Zhu, Bowen Tan, Hanxin Zhao, Chengxin Shang, Fenping Zheng, Xihua Lin, Hong Li, Wei-Ping Jia. Knockdown of insulin-like growth factor 2 gene disrupts mitochondrial functions in the liverJournal of Molecular Cell Biology 2021;  doi: 10.1093/jmcb/mjab030